Dr. Feng ISC25 LB16 suprised by TRANSPORT 2 results
Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Transcript (txt)
copyright American Heart Association 2025
Please see AHA/ASA Multimedia Materials Usage Policy.
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE
PROCEED